Product Information
CLEMSZA 2.68 MG TABLET is a generic product labeled by IPG Pharmaceuticals, Inc., priced at $3.1775 per EA under NDC 71085008130. Its NADAC has been published 37 times since Jan 21, 2026.
FDA first approved this application on Jan 31, 1992.
Strength
2.68 mg/1
Manufacturer
IPG Pharmaceuticals, Inc.NDC
71085008130
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
CLEMASTINE FUMARATEApproval Type
Generic (ANDA)
FDA Application
ANDA073283FDA Approved
1/31/1992
On Market Since
8/1/2025
Price Statistics
The NADAC for CLEMSZA 2.68 MG TABLET has been published 37 times since Jan 21, 2026, and over the history we have for it it has declined 4.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $3.1775 per EA |
|---|---|
| All-time high | $3.3560 (Apr 15, 2026) |
| All-time low | $3.1775 (Sep 23, 2026) |
| 52-week high | $3.3560 |
| 52-week low | $3.1775 |
| Median price | $3.3228 |
| Average price | $3.3069 |
| Largest weekly change | -3.1% (Aug 19, 2026) |
| Weeks tracked | 37 |
| Tracking since | Jan 21, 2026 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
IPG Pharmaceuticals, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Clemastine Fumarate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CLEMSZA 2.68 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CLEMSZA 2.68 MG TABLET, manufactured by IPG Pharmaceuticals, Inc., is $3.1775 per EA (NDC 71085008130), effective Sep 30, 2026.
How has the price of CLEMSZA 2.68 MG TABLET changed over time?
Over the history we have for it, the NADAC for CLEMSZA 2.68 MG TABLET has declined 4.4%. It has been tracked across 37 weekly CMS publications since Jan 21, 2026.
What are the highest and lowest recorded NADAC prices for CLEMSZA 2.68 MG TABLET?
Since Jan 21, 2026, the NADAC for CLEMSZA 2.68 MG TABLET has ranged from a low of $3.1775 (Sep 23, 2026) to a high of $3.3560 (Apr 15, 2026), with a median of $3.3228 per EA.
Are there cheaper alternatives to CLEMSZA 2.68 MG TABLET?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CLEMSZA 2.68 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures CLEMSZA 2.68 MG TABLET?
CLEMSZA 2.68 MG TABLET (NDC 71085008130) is labeled by IPG Pharmaceuticals, Inc., and CMS classifies it as a generic product.